{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:18:51Z","timestamp":1792289931677,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.toxicon.2009.03.010","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T04:52:38Z","timestamp":1237265558000},"page":"697-701","source":"Crossref","is-referenced-by-count":45,"title":["Xeomin is free from complexing proteins"],"prefix":"10.1016","volume":"54","author":[{"given":"J\u00fcrgen","family":"Frevert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2009.03.010_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"11","author":"Benecke","year":"2005","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2009.03.010_bib2","first-page":"9","article-title":"An histological assessment of diffusion of different botulinum neurotoxin type A formulations injected in the mice leg","volume":"51","author":"Carli","year":"2008","journal-title":"Toxicon"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2009.03.010_bib3","first-page":"10","article-title":"Equivalent potency of Xeomin\u00ae and BOTOX\u00ae","volume":"51","author":"Dressler","year":"2008","journal-title":"Toxicon"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2009.03.010_bib4","first-page":"10","article-title":"Dissociation of the 900kDa neurotoxin complex from C. botulinum under physiological conditions","volume":"51","author":"Eisele","year":"2008","journal-title":"Toxicon"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2009.03.010_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.toxicon.2008.04.038","article-title":"Xeomin\u00ae is stable without refrigeration: complexing proteins are not required for stability of botulinum neurotoxin type A preparations","volume":"51","author":"Grein","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2009.03.010_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-200767050-00003","article-title":"Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia","volume":"67","author":"Jost","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.toxicon.2009.03.010_bib7","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1099\/mic.0.28421-0","article-title":"Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin","volume":"151","author":"Lee","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.toxicon.2009.03.010_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenk\u00e4mper","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxicon.2009.03.010_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.WNF.0000240951.18821.50","article-title":"Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins","volume":"30","author":"Wohlfarth","year":"2007","journal-title":"Clin. Neuropharmacol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T21:29:58Z","timestamp":1545341398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010109001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041010109001603"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2009.03.010","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}